Skip to main content
. 2005 Oct 10;92(5):664–670. doi: 10.1136/hrt.2005.072314

Table 3 Secondary PH clinical summary.

Patient Sex Age (years) Diagnosis Mean PAP (mm Hg) PVR (units⋅m2) Treatment duration (months) WHO class Six minutes walk Weight (kg)
Baseline Change Baseline % Change Baseline % Change
1 F 1.7 AVSD (E) 57 12 22 III −1 8.7 18
2 M 2.7 TGA/Rastelli 37 36.1 22 IV 0 10 55
3 F 4.2 AVSD, po 38 4.9 16 III −1 240 76 15.3 16
4 F 4.3 AVSD, po 20 7 III 0 15 11
5 M 5.8 TGA, VSD Switch 57 9.4 12 III −1 110 183.5 13.4 6.7
6 F 10.1 AVSD (E) 83 36.9 17 III 0 80 125 27.9 12
7 F 11.3 TA,VSD (E)† 38 18.7 11 IV −1 210 24.5 18.5 19
8 M 14.2 TAPVD, po 53 13.3 19 IV −1 310 36 25.8 9.26
9 M 14.3 TGA/Senning 51 8.1 18 III −1 290 82 59.3 17
10 M 15.1 DORV (E) 72 17.3 11 III 0 80 127.5 44.1 7.5
11* F 15.2 TGA/Senning 53 18.4 16 IV −1 160 187.5 42.1 7.7
12 F 15.7 pAVSD, po 49 13.2 7 III 0 400 7.5 31 4.5
13 F 0.6 CLD 2 IV 0 6.8 25
14 F 1.9 CLD 32 10.1 19 III −1 9.3 0
15 M 2.4 CLD 78 49 12 III −1 12 29
16* M 3.3 Systemic sclerosis + SAH 43 8 8 III 0 9.6 −6.7
17 M 7.3 Diffuse interstitial lung disease + SAH 48 19.1 6 IV 0 33.5 7.2
18 M 8.1 Cutis marmorata 43 8.25 5 III −1 312 33.3 19.9 22.4
19 F 12.25 CT disorder/pulmonary fibrosis + SAH 9 IV –1 32.8 19.6
20 F 16 HIV 80 22.1 6 III 0 340 −5.8 44.4 4.95

*Taking epoprostenol at start; †repaired truncus arteriosus with interrupted left pulmonary artery and residual ventricular septal defect (VSD).

AVSD, atrioventricular septal defect; CLD, chronic lung disease; CT, connective tissue; DORV, double outlet right ventricle; E, Eisenmenger's syndrome; pAVSD, partial atrioventricular septal defect; po, postoperative; SAH, systemic arterial hypertension; TA, truncus arteriosus; TAPVD, total anomalous pulmonary venous drainage; TGA, transposition of the great arteries.